Clemson Women's Basketball

Clemson Hosts Lander in Exhibition Play

October 28, 2018

CLEMSON, S.C. - The Clemson women’s basketball team takes the court for the first time this season when it hosts Lander at 2 p.m. on Sunday for the first of two exhibition games. Fans are invited to Littlejohn to get their first look at the 2018-19 Tigers under new head coach Amanda Butler. Admission to both exhibition games is free.

The Tigers return seven play­ers from a season ago, including leading scor­er Kobi Thornton, who averaged 11.1 points per game in 2017-18. Clemson welcomes six new faces - three freshmen and three trans­fers - to round out the squad of 13. Grad­uate transfer Simone Westbrook joins the program from Florida as the only current Tiger to have played under Coach Butler.

Clemson faces off with Lander for just the third time in program his­tory. The Tigers hold the 2-0 edge over the Bearcats, emerging victorious, 94-50, in the last meeting between the two programs on Feb. 13, 1978, a home game for Clem­son. Lander head coach Kevin Pederson has Clemson roots having worked as a manager for the men’s basketball team for five seasons before graduating from Clemson in 1999.

The Tigers roll into the 2018-19 season with a top-notch defense from a season ago. Clemson held opponents to 60.3 points per game, ranking fifth in the ACC in both scoring defense and field goal percentage defense. Danielle Edwards sat second in the ACC in steals, averaging 2.6 steals per game during the 2017-18 season. She is just 34 steals from sneaking into the top five in program history for career steals.

All single game tickets are on sale for adult and youth/seniors at $6 and $4, respectively. Children 12 and under are free. Single-game and season tickets can be purchased online or at 1-800-CLEMSON. All seats for women’s basketball are general admission.

Clemson Hosts Lander in Exhibition Play

There are not any replies to this post yet.
Page 1 of 1
Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.